Contemporary management of aortic stenosis: Surgical aortic valve replacement remains the gold standard

Heart

Volumn 98, Issue SUPPL. 4, 2012, Pages

  Walther, Thomas ^a   Blumenstein, Johannes ^a   Van Linden, Arnaud ^a   Kempfert, Jörg ^a  

^a KERCKHOFF HEART CENTER   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

AORTA STENOSIS; AORTA VALVE PROSTHESIS; AORTA VALVE REGURGITATION; AORTA VALVE REPLACEMENT; BLOOD VESSEL CALCIFICATION; CEREBROVASCULAR ACCIDENT; COMORBIDITY; GERIATRIC PATIENT; GOLD STANDARD; HEART VALVE BIOPROSTHESIS; HIGH RISK PATIENT; HUMAN; MINIMALLY INVASIVE CARDIAC SURGERY; NITINOL STENT; OVERALL SURVIVAL; PRIORITY JOURNAL; PROGNOSIS; QUALITY OF LIFE; REVIEW; RISK ASSESSMENT; SCORING SYSTEM; SELF EXPANDING STENT; STERNOTOMY; SURGICAL MORTALITY; SURGICAL TECHNIQUE; SURVIVAL RATE; TRANSCATHETER AORTIC VALVE IMPLANTATION;

AORTIC VALVE; AORTIC VALVE STENOSIS; HEART VALVE PROSTHESIS IMPLANTATION; HUMANS; TREATMENT OUTCOME;

EID: 84869019412     PISSN: 13556037     EISSN: 1468201X     Source Type: Journal    
DOI: 10.1136/heartjnl-2012-302399     Document Type: Review

References (34)

1. Iung B, Baron G, Butchart EG, et al. A prospective survey of patients with valvular heart disease in Europe: The Euro Heart Survey on Valvular Heart Disease. Eur Heart J 2003;24:1231-43.
2. Vahanian A, Alfieri O, Andreotti F, et al. Guidelines on the management of valvular heart disease (version 2012): the Joint Task Force on the Management of Valvular Heart Disease of the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS). Eur Heart J 2012;33:2451-96.
3. Vahanian A, Alfieri O, Al-Attar N, et al. European Association of Cardio-Thoracic Surgery, European Society of Cardiology, European Association of Percutaneous Cardiovascular Interventions. Transcatheter valve implantation for patients with aortic stenosis: a position statement from the European Association of Cardio-Thoracic Surgery (EACTS) and the European Society of Cardiology (ESC), in collaboration with the European Association of Percutaneous Cardiovascular Interventions (EAPCI). Eur Heart J 2008;29:1463-70.
4. Gummert JF, Funkat AK, Beckmann A, et al. Cardiac surgery in Germany during 2010: a report on behalf of the German Society for Thoracic and Cardiovascular Surgery. Thorac Cardiovasc Surg 2011;59:259-67.
5. Nkomo VT, Gardin JM, Skelton TN, et al. Burden of valvular heart diseases: a population-based study. Lancet 2006;368:1005-11.
6. Cribier A, Eltchaninoff H, Bash A, et al. Percutaneous transcatheter implantation of an aortic valve prosthesis for calcific aortic stenosis: first human case description. Circulation 2002;106:3006-8.
7. Vicchio M, Della Corte A, De Santo LS, et al. Tissue versus mechanical prostheses: quality of life in octogenarians. Ann Thorac Surg 2008;85:1290-5.
8. Walther T, Falk V, Mohr FW. Minimally invasive surgery for valve disease. Curr Probl Cardiol 2006;31:393-438.
9. ElBardissi AW, Shekar P, Couper GS, et al. Minimally invasive aortic valve replacement in octogenarian, high-risk, transcatheter aortic valve implantation candidates. J Thorac Cardiovasc Surg 2011;141:328-35.
10. Brown ML, McKellar SH, Sundt TM, et al. Ministernotomy versus conventional sternotomy for aortic valve replacement: a systematic review and meta-analysis. J Thorac Cardiovasc Surg 2009;137:670-9.
11. Martens S, Sadowski J, Eckstein FS, et al. Clinical experience with the ATS 3f Enable® Sutureless Bioprosthesis. Eur J Cardiothorac Surg 2011;40:749-55.
12. Emery RW, Krogh CC, Arom KV, et al. The St. Jude Medical cardiac valve prosthesis: a 25-year experience with single valve replacement. Ann Thorac Surg 2005;79:776-82.
13. Jamieson WRE, Burr LH, Miyagishima RT, et al. Carpentier-Edwards supra-annular aortic porcine bioprosthesis: clinical performance over 20 years. J Thorac Cardiovasc Surg 2005;130:994-1000.
14. Kempfert J, Van Linden A, Linke A, et al. Transapical off-pump valve-in-valve implantation in patients with degenerated aortic xenografts. Ann Thorac Surg 2010;89:1934-41.
15. Khan SS, Trento A, DeRobertis M, et al. Twenty-year comparison of tissue and mechanical valve replacement. J Thorac Cardiovasc Surg 2001;122:257-69.
16. Hammermeister K, Sethi GK, Henderson WG, et al. Outcomes 15 years after valve replacement with a mechanical versus a bioprosthetic valve: final report of the Veterans Affairs randomized trial. J Am Coll Cardiol 2000;36:1152-8.
17. Tang GH, Maganti M, David TE, et al. Effect of prior valve type on mortality in reoperative valve surgery. Ann Thorac Surg 2007;83:938-45.
18. Ashikhmina EA, Schaff HV, Dearani JA, et al. Aortic valve replacement in the elderly: determinants of late outcome. Circulation 2011;124:1070-8.
19. Leontyev S, Walther T, Borger MA, et al. Aortic valve replacement in octogenarians: utility of risk stratification with EuroSCORE. Ann Thorac Surg 2009;87:1440-5.
20. Vasques F, Messori A, Lucenteforte E, et al. Immediate and late outcome of patients aged 80 years and older undergoing isolated aortic valve replacement: a systematic review and meta-analysis of 48 studies. Am Heart J 2012;163:477-85.
21. Smith CR, Leon MB, Mack MJ, et al., PARTNER Trial Investigators. Transcatheter versus surgical aortic-valve replacement in high-risk patients. N Engl J Med 2011;364:2187-98.
22. Leon MB, Smith CR, Mack M, et al., PARTNER Trial Investigators. Transcatheter aortic-valve implantation for aortic stenosis in patients who cannot undergo surgery. N Engl J Med 2010;363:1597-607.
23. Walther T, Schuler G, Borger MA, et al. Transapical aortic valve implantation in 100 consecutive patients: comparison to propensity-matched conventional aortic valve replacement. Eur Heart J 2010;31:1398-403.
24. Filsoufi F, Rahmanian PB, Castillo JG, et al. Incidence, imaging analysis, and early and late outcomes of stroke after cardiac valve operation. Am J Cardiol 2008;101:1472-8.
25. Miller DC, Blackstone EH, Mack MJ, et al., The PARTNER Trial Investigators and Patients, The PARTNER Stroke Substudy Writing Group and Executive Committee: Transcatheter (TAVR) versus surgical (AVR) aortic valve replacement. Occurrence, hazard, risk factors, and consequences of neurologic events in the PARTNER trial. J Thorac Cardiovasc Surg 2012;143:832-43.
26. Sündermann S, Dademasch A, Praetorius J, et al. Comprehensive assessment of frailty for elderly high-risk patients undergoing cardiac surgery. Eur J Cardiothorac Surg 2011;39:33-7.
27. Colli A, D'Amico R, Kempfert J, et al. Transesophageal echocardiographic scoring for transcatheter aortic valve implantation: impact of aortic cusp calcification on postoperative aortic regurgitation. J Thorac Cardiovasc Surg 2011;142:1229-35.
28. Nashef SAM, Roques F, Michel P, et al., the EuroSCORE Study Group. European System for Cardiac Operative Risk Evaluation (EuroSCORE). Eur J Cardiothorac Surg 1999;16:9-13.
29. Wendt D, Osswald BR, Kayser K, et al., Society of Thoracic Surgeons score is superior to the EuroSCORE determining mortality in high risk patients undergoing isolated aortic valve replacement. Ann Thorac Surg 2009;88:468-74; discussion 474-5.
30. Nashef SAM, Roques F, Sharples LD, et al., EuroSCORE II. Eur J Cardiothorac Surg 2012;41:734-45.
31. Eggebrecht H, Schmermund A, Voigtlander T, et al. Risk of stroke after transcatheter aortic valve implantation (TAVI): a meta-analysis of 10,037 published patients. EuroIntervention 2012;15:129-38.
32. Jilaihawi H, Chin D, Vasa-Nicotera M, et al. Predictors for permanent pacemaker requirement after transcatheter aortic valve implantation with the CoreValve bioprosthesis. Am Heart J 2009;157:860-6.
33. Khawaja M, Rajani R, Cook A, et al. Permanent pacemaker insertion after CoreValve transcatheter aortic valve implantation: incidence and contributing factors (the UK CoreValve Collaborative). Circulation 2011;123:951-60.
34. Tamburino C, Capodanno D, Ramondo A, et al. Incidence and predictors of early and late mortality after transcatheter aortic valve implantation in 663 patients with severe aortic stenosis. Circulation 2011;123:299-308.